Fecal microbiome analysis as a diagnostic test for diverticulitis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 11, 2014, Pages 1927-1936

  Daniels, L ^a   Budding, A E ^b   de Korte, N ^c   Eck, A ^b   Bogaards, J A ^b   Stockmann, H B ^c   Consten, E C ^d   Savelkoul, P H ^b,e   Boermeester, M A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Orthopaedic Surgery   (Netherlands)

^d MEANDER MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSAY; BACTERIUM DETECTION; BACTEROIDETES; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIVERTICULITIS; ENTEROBACTERIACEAE; FECES MICROFLORA; FEMALE; FIRMICUTES; GENETIC ANALYZER; HUMAN; INTESTINE FLORA; MALE; MICROBIOME; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRINCIPAL COORDINATE ANALYSIS; PROTEOBACTERIA; ADOLESCENT; AGED; BIOSTATISTICS; CLINICAL TRIAL; EVALUATION STUDY; FECES; HIGH THROUGHPUT SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOLECULAR DIAGNOSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIOLOGICAL TECHNIQUES; BIOSTATISTICS; DIAGNOSTIC TESTS, ROUTINE; DIVERTICULITIS; FECES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84911001650     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2162-3     Document Type: Article

References (48)

1. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118:229–241
2. Bäckhed F, Ding H, Wang T et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101:15718–15723
3. Stappenbeck TS, Hooper LV, Gordon JI (2002) Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 99:15451–15455
4. Garrett WS, Gordon JI, Glimcher LH (2010) Homeostasis and inflammation in the intestine. Cell 140:859–870
5. Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10:159–169
6. Clarridge JE 3rd (2004) Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev 17:840–862
7. Budding AE, Grasman ME, Lin F et al (2010) IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J 24:4556–4564
8. Eckburg PB, Bik EM, Bernstein CN et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638
9. Dethlefsen L, Huse S, Sogin ML et al (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280
10. Wang X, Heazlewood SP, Krause DO et al (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95:508–520
11. Zoetendal EG, Akkermans ADL, de Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854–3859
12. Faith JJ, Guruge JL, Charbonneau M et al (2013) The long-term stability of the human gut microbiota. Science 341:1237439
13. Frank DN, St Amand AL, Feldman RA et al (2007) Molecular–phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104:13780–13785
14. Zoetendal EG, von Wright A, Vilpponen-Salmela T et al (2002) Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 68:3401–3407
15. Sokol H, Pigneur B, Watterlot L et al (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731–16736
16. Swidsinski A, Loening-Baucke V, Vaneechoutte M et al (2008) Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 14:147–161
17. Ley RE, Turnbaugh PJ, Klein S et al (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023
18. Turnbaugh PJ, Ley RE, Mahowald MA et al (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031
19. Swidsinski A, Dörffel Y, Loening-Baucke V et al (2011) Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60:34–40
20. Floch MH (2006) A hypothesis: is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol 40(Suppl 3):S121–S125
21. Jacobs DO (2007) Clinical practice. Diverticulitis. N Engl J Med 357:2057–2066
22. Unlü C, de Korte N, Daniels L et al; Dutch Diverticular Disease 3D Collaborative Study Group (2010) A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg 10:23
23. Wasvary H, Turfah F, Kadro O et al (1999) Same hospitalization resection for acute diverticulitis. Am Surg 65:632–635
24. Parks TG (1969) Natural history of diverticular disease of the colon. A review of 521 cases. Br Med J 4:639–642
25. Mendeloff AI (1986) Thoughts on the epidemiology of diverticular disease. Clin Gastroenterol 15:855–877
26. Syed SA, Loesche WJ (1972) Survival of human dental plaque flora in various transport media. Appl Microbiol 24:638–644
27. Haegeman B, Hamelin J, Moriarty J et al (2013) Robust estimation of microbial diversity in theory and in practice. ISME J 7:1092–1101
28. Rajilić-Stojanović M, Biagi E, Heilig HG et al (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801
29. Hastie T, Tibshirani R, Friedman J (2001) The elements of statistical learning. Springer, New York
30. Pérez-Enciso M, Tenenhaus M (2003) Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet 112:581–592
31. Nguyen DV, Rocke DM (2002) Tumor classification by partial least squares using microarray gene expression data. Bioinformatics 18:39–50
32. Modlich O, Prisack HB, Munnes M et al (2005) Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures. J Transl Med 3:32
33. Diaz SO, Barros AS, Goodfellow BJ et al (2013) Second trimester maternal urine for the diagnosis of trisomy 21 and prediction of poor pregnancy outcomes. J Proteome Res 12:2946–2957
34. Tap J, Mondot S, Levenez F et al (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11:2574–2584
35. Brook I, Frazier EH (2000) Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 49:827–830
36. Gueimonde M, Ouwehand A, Huhtinen H et al (2007) Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 13:3985–3989
37. de Korte N, Unlü C, Boermeester MA et al (2011) Use of antibiotics in uncomplicated diverticulitis. Br J Surg 98:761–767
38. Chabok A, Påhlman L, Hjern F et al; AVOD Study Group (2012) Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg 99:532–539
39. Colecchia A, Vestito A, Pasqui F et al (2007) Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 13:264–269
40. Papi C, Ciaco A, Koch M et al (1992) Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 24:452–456
41. Latella G, Pimpo MT, Sottili S et al (2003) Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18:55–62
42. Papi C, Ciaco A, Koch M et al (1995) Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9:33–39
43. Porta E, Germano A, Ferrieri A et al (1994) The natural history of diverticular disease of the colon: A role for antibiotics in preventing complications? A retrospective study. Riv Eur Sci Med Farmacol 16:33–39
44. Tursi A, Brandimarte G, Giorgetti GM et al (2007) Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 22:1103–1108
45. Dughera L, Serra AM, Battaglia E et al (2004) Acute recurrent diverticulitis is prevented by oral administration of a polybacterial lysate suspension. Minerva Gastroenterol Dietol 50:149–153
46. Frič P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15:313–315
47. Lamiki P, Tsuchiya J, Pathak S et al (2010) Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis 19:31–36
48. Laméris W, van Randen A, van Gulik TM et al (2010) A clinical decision rule to establish the diagnosis of acute diverticulitis at the emergency department. Dis Colon Rectum 53:896–904